STOCK OPTIONS AND WARRANTS | 18 - STOCK OPTIONS AND WARRANTS Options During the year ended December 31, 2023 and December 31, 2022, the Company granted options to purchase an aggregate of 275,000 3,826,500 3.89 3.28 The fair value of each option award was estimated on the date of grant using the Black-Scholes option valuation model using the assumptions noted as follows: expected volatility was based on the historical volatility of a peer group of companies. The expected term of options granted was determined using the simplified method under SAB 107 which represents the mid-point between the vesting term and the contractual term. The risk-free rate is calculated using the U.S. Treasury yield curve and is based on the expected term of the option. The Black-Scholes option pricing model was used with the following weighted assumptions for options granted: Schedule of Black-Scholes option pricing model was used with the following weighted assumptions for options granted December 31, Risk-free interest rate 3.12 4.70 % Expected option life 6 48 Expected volatility 37.98 62.43 % Expected dividend yield – % Exercise price $ 1.40 4.00 The following table summarizes stock option activity for the year ended December 31, 2023: Schedule of stock option activity Number of Weighted Weighted Aggregate Outstanding at December 31, 2022 1,910,484 $ 4.00 9.8 $ - Granted 275,000 3.89 Exercised (20,000 ) 1.76 Expired - - Forfeited (418,599 ) 2.17 Outstanding at December 31, 2023 1,746,885 $ 2.86 9.0 $ 5,427,118 Exercisable at December 31, 2023 489,295 $ 2.70 8.8 $ 1,599,251 The Company is expensing these stock option awards on a straight-line basis over the requisite service period. The Company recognized stock option expense of $ 617,819 751,776 1,291,367 1.2 A schedule of the Company’s nonvested options as of December 31, 2023, is presented below: Schedule of status of non-vested options Number of Weighted Average Nonvested options at December 31, 2022 1,910,484 $ 2.55 Granted 275,000 3.89 Forfeited (418,599 ) 2.17 Vested (509,295 ) 2.66 Nonvested options at December 31, 2023 1,257,590 $ 2.93 Warrants In connection with certain private placements funded by certain of the Company’s officers and directors prior to the Company’s initial public offering, the Company issued promissory notes and warrants. The warrants were contingent upon, and became effective upon, consummation of the Company’s initial public offering on August 11, 2022. In total, warrants to purchase up to 695,000 4.20 5 Also, in conjunction with the initial public offering, the Company issued warrants to purchase up to 135,000 4.40 5 Also, in connection with certain private placements with Greenle, the Company issued warrants to purchase up to 920,000 4.00 5 . 32,000 4.40 5 On September 16, 2022, September 30, 2022, and October 30, 2022 in conjunction with a financing with the same third-party investor, the Company issued warrants to purchase up to 517,500 352,188 366,562 4.00 On February 15, 2023, in conjunction with an advisory agreement, the Company issued warrants to purchase up to 250,000 shares of our common stock with an exercise price of $4.00 per share. These warrants have a term of five years and expire in February 2028. As a result of these transaction, the Company recorded $ 167,573 On April 16, 2023 in conjunction with an agreement with certain lenders, the Company issued warrants to purchase up to 1,000,000 shares of the Company’s common stock with an exercise price of $3.00 per share, and warrants to purchase up to 250,000 shares of our common stock with an exercise price of $4.00 per share. All of these warrants have a term of 5 years and expire in April of 2028. Under this agreement, these lenders would be required to exercise all or a portion of these warrants if the Company’s common stock traded at prices between $3.00 per share and $4.00 per share for a prescribed number of trading days. On June 19, 2023, this agreement was modified to convert all of related outstanding debt in exchange for a reduction in the exercise price of all of these warrants to $2.50 per share. 259,074 On November 6, 2023, in conjunction with an agreement with certain shareholders to amend agreements to waive registration rights for any currently issued common stock for a period of 12 months and any future issuances for a rolling 12-month period from the date such of issuance of such common stock. As consideration for this waiver, the Company issued 2,000,000 4.00 4,939,000 On December 17, 2023, the Company and certain existing warrant holders entered into an agreement pursuant to which these warrant holders exercised a portion of their existing warrants to purchase an aggregate of 1,000,000 4,000,000 2,000,000 5.00 $4,187,800 On December 27, 2023, the Company and certain existing warrant holders entered into an agreement pursuant to which these warrant holders exercised a portion of their existing warrants to purchase an aggregate of 500,000 2,000,000 1,000,000 5.50 3,081,400 The following table summarizes warrant activity for the twelve months ended December 31, 2023: Schedule of warrant activity Number of Weighted Weighted Aggregate Outstanding at December 31, 2022 3,018,250 $ 2.64 4.8 $ - Issued 6,500,000 4.25 Exercised (4,076,250 ) 2.49 Expired - - Outstanding at December 31, 2023 5,442,000 $ 4.68 4.7 $ 7,038,940 Exercisable at December 31, 2023 5,442,000 $ 4.68 4.7 $ 7,038,940 In the year ended December 31, 2022, no shares were issued from the exercise of warrants. |